- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Potentially Undervalued Companies
Norwegian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
4
0 new
Companies with a Value score of at least 3, ordered by Value score
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CRNA | NOK 0.71 | 4.1% | -91.0% | NOK 32.2m | NOK 2.00 | PE3.4x | E61.2% | n/a | ||
VISTN | NOK 24.40 | 2.5% | 5.2% | NOK 1.1b | n/a | PE17.6x | n/a | 4.1% | ||
ABS | NOK 1.95 | -2.5% | -78.6% | NOK 49.5m | n/a | PS1.6x | E-12.8% | n/a | ||
NAVA | NOK 25.90 | -7.5% | -29.6% | NOK 457.5m | NOK 37.00 | PE23.3x | E29.6% | n/a |
Page 1 of 1